TG Therapeutics, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	204.9M	192.6M	161.7M	141.1M	120.9M	108.2M	83.9M	73.5M
Cost of Goods Sold	33.5M	38.1M	28.2M	18.9M	15.5M	15.4M	9.3M	8.3M
Gross Profit	171.4M	154.4M	133.6M	122.2M	105.3M	92.8M	74.5M	65.2M
R&D Expenses	43.5M	41.2M	40.9M	31.8M	46.4M	23.9M	20.1M	17.6M
Operating Expenses	136.6M	103.9M	104.2M	87.4M	96.7M	62.8M	62.1M	56.3M
Operating Income	34.8M	50.5M	29.4M	34.8M	8.6M	29.9M	12.4M	8.8M
Other Income / Gains	-14.4M	-5.4M	-3.5M	-3.9M	-3.2M	-4.5M	-8.2M	-2.3M
Net Income	19.8M	23.0M	390.9M	28.2M	5.1M	23.3M	3.9M	6.9M
EPS (Diluted)	0.14	0.16	2.69	0.19	0.035	0.16	0.03	0.048
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.836	0.802	0.826	0.866	0.871	0.858	0.889	0.887
General And Administrative Expenses	0	62.7M	63.4M	55.6M	50.3M	39.0M	42.0M	38.8M
Selling And Marketing Expenses	0	0	0	0	0	0	0	-72K
Selling General And Administrative Expenses	73.1M	62.7M	63.3M	55.6M	50.3M	39.0M	42.0M	38.7M
Other Expenses	19.9M	0	0	0	0	0	0	72K
Cost And Expenses	170.1M	142.1M	132.3M	106.3M	112.2M	78.2M	71.4M	64.7M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	7.7M	6.5M	6.7M	6.7M	6.8M	7.1M	10.8M	4.0M
Depreciation And Amortization	80K	67K	62K	59K	56K	62K	64K	72K
Ebitda	34.8M	51.7M	32.7M	37.7M	12.3M	32.6M	15.2M	10.6M
Ebitdaratio	0.17	0.268	0.202	0.267	0.102	0.301	0.181	0.144
Operating Income Ratio	0.17	0.262	0.182	0.247	0.071	0.277	0.148	0.12
Income Before Tax	20.4M	45.1M	25.9M	30.9M	5.5M	25.5M	4.3M	6.6M
Income Before Tax Ratio	0.099	0.234	0.16	0.219	0.045	0.235	0.051	0.089
Income Tax Expense	586K	22.1M	-365.0M	2.7M	408K	2.1M	388K	-328K
Net Income Ratio	0.097	0.12	2.417	0.20	0.042	0.216	0.046	0.094
Epsdiluted	0.12	0.14	2.43	0.17	0.031	0.15	0.02	0.043
Weighted Average Shs Out	144.4M	143.0M	145.4M	146.7M	146.7M	145.2M	145.1M	144.7M
Weighted Average Shs Out Dil	160.1M	159.4M	161.0M	162.6M	162.8M	160.2M	160.7M	159.4M